D(-)-Arginine CAS 157-06-2
D(-)-Arginine Basic information
| Product Name: | D(-)-Arginine |
| Synonyms: | (2R)-2-ammonio-5-(diaminomethylideneammonio)pentanoate;R-(-)-ARGININE;(R)-2-AMINO-5-GUANIDINOPENTANOIC ACID;RARECHEM AB PP 1748;D-ARG;D-(-)-ARGININE;D-ARGININE;D-2-AMINO-5-GUANIDINOVALERIC ACID |
| CAS: | 157-06-2 |
| MF: | C6H14N4O2 |
| MW: | 174.2 |
| EINECS: | 205-866-5 |
| Product Categories: | amino;Amino Acids;Arginine [Arg, R];Amino Acids and Derivatives;alpha-Amino Acids;Amino Acids;Biochemistry;for Resolution of Acids;Optical Resolution;Synthetic Organic Chemistry;PROTECTED AMINO ACID & PEPTIDES;Amino Acids Derivatives;chiral |
| Mol File: | 157-06-2.mol |
D(-)-Arginine Chemical Properties
| Melting point | 226 °C (dec.) (lit.) |
| alpha | -28.5 º (c=8, 6 N HCl) |
| Boiling point | 305.18°C (rough estimate) |
| density | 1.2297 (rough estimate) |
| refractive index | -23 ° (C=8, 6mol/L HCl) |
| storage temp. | Keep in dark place,Inert atmosphere,Room temperature |
| solubility | Aqueous Acid (Slightly), Water (Slightly) |
| pka | 2.49±0.24(Predicted) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | SOLUBLE |
| Sensitive | Air Sensitive |
| BRN | 1725412 |
| Major Application | peptide synthesis |
| InChI | 1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m1/s1 |
| InChIKey | ODKSFYDXXFIFQN-SCSAIBSYSA-N |
| SMILES | N[C@H](CCCNC(N)=N)C(O)=O |
| LogP | -0.999 (est) |
| CAS DataBase Reference | 157-06-2(CAS DataBase Reference) |
| EPA Substance Registry System | D-Arginine (157-06-2) |
Safety Information
| Hazard Codes | Xi,Xn |
| Risk Statements | 36-36/37/38-20/21/22 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | CF1934220 |
| F | 9 |
| TSCA | TSCA listed |
| HazardClass | IRRITANT |
| HS Code | 29252000 |
| Storage Class | 11 - Combustible Solids |
| Description | D-arginine is the D-form of arginine, which is a kind of amino acids. It can be reacted with hydrogen peroxide for non-enzymatic synthesis of nitric oxide. It has certain pharmacological activities. For example, its derivative, 1-deamino-8-D-arginine vasopressin is useful for the management of haemophilia and von Willebrand’s disease. It also has the potential to inhibit the proliferation of certain cancer cells. In biological research, D-arginine is frequently used in the studies of L-arginine/nitric oxide pathway as an inactive form of L-arginine. | ||||||||
| Chemical Properties | white to light yellow crystal powde | ||||||||
| Uses | Arginine is an essential amino acid found in food and plant sources, and many biological systems. D-Arginine is extensively used in studies on L-arginine/nitric oxide pathway as an inactive form of L-arginine, even in man. D-Arginine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). D-Arginine can be found in human epidermis and platelet tissues. Within the cell, D-arginine is primarily located in the peroxisome. D-Arginine specifically can inhibit arginine decarboxylase enzymes and also functions as a metabolite. | ||||||||
| Uses | 1-Deamino-8-D-arginine vasopressin makes a new pharmacological approach to the management of haemophilia and von Willebrand's disease. A novel nonenzymatic pathway for the generation of nitric oxide is by the reaction of hydrogen peroxide and d- or l-arginine. | ||||||||
| Definition | ChEBI: D-arginine is a D-alpha-amino acid that is the D-isomer of arginine. It has a role as an EC 4.1.1.19 (arginine decarboxylase) inhibitor and a mouse metabolite. It is a D-alpha-amino acid and an arginine. It is a conjugate base of a D-argininium(1+). It is a conjugate acid of a D-argininate. It is an enantiomer of a L-arginine. | ||||||||
| in vivo | D-arginine (1 mg/kg, i.v., caudal veins, every two days) sensitize osteosarcoma to radiotherapy in a mouse model of subcutaneous osteosarcoma[3].
| ||||||||
| IC 50 | Human Endogenous Metabolite | ||||||||
| References | https://www.alfa.com/zh-cn/catalog/A16137/ Iannucci, N. B., et al. "Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells." Future Medicinal Chemistry 3.16(2011):1987-1993. Ripoll, Giselle, et al. "Angiostatic activity of 1-Deamino-8-D-Arginine vasopressin and novel peptide analogues in breast cancer cells." Cancer Research 68(2008). Navarro, Eduardo, et al. "Toxicological and Pharmacological Effects of D-Arginine." Basic & Clinical Pharmacology & Toxicology97.3(2005):149-154. |
D(-)-Arginine Preparation Products And Raw materials
| Raw materials | D-Ornithine monohydrochloride |
